Preclinical efficacy and immunogenicity assessment to show that a chimericPlasmodium falciparumUB05-09 antigen could be a malaria vaccine candidate

Author:

Dinga J. N.12ORCID,Gamua S. D.2,Ghogomu S. M.2,Titanji V. P. K.13

Affiliation:

1. Biotechnology Unit; Faculty of Science; University of Buea; Buea Cameroon

2. Department of Biochemistry and Molecular Biology; Faculty of Science; University of Buea; Buea Cameroon

3. Faculty of Science, Engineering and Technology; Cameroon Christian University Institute; Bali Cameroon

Funder

Africa Biosciences Challenge Fund Fellowship

International Society for Infectious Diseases

Department of Foreign Affairs and Trade, Australian Government

Syngenta Foundation for Sustainable Agriculture

Bill and Melinda Gates Foundation

Department for International Development

Styrelsen för Internationellt Utvecklingssamarbete

Publisher

Wiley

Subject

Immunology,Parasitology

Reference34 articles.

1. World Health Organization World Malaria Report 2016 World Health 2016 186

2. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines;Patarroyo Manuel;Acc Chem Res,2008

3. A rational approach for predicting the minimum composition of anti-parasite sub-unit vaccines: A multiple target vaccine hypothesis;Titanji;Journal of the Cameroon Academy of Sciences,2017

4. MVI PATH and GlaxoSmithKline RELEASE Malaria vaccine candidate has demonstrated efficacy over 3-4 years of follow-up 2015

5. The future of the RTS, S/AS01 malaria vaccine: an alternative development plan;Gosling;PLoS Med,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3